HPV and condom labeling
This article was originally published in The Gray Sheet
Executive Summary
House Government Reform/Human Resources Subcommittee hearing Jan. 28 on human papillomavirus and the "best strategies" to prevent HPV infection postponed until Feb. 5 (1"The Gray Sheet" Jan.12, 2004, p. 17). The National Cancer Institute had been asked to testify on HPV and cervical cancer vaccine research, diagnostic technologies, treatment options, consequences and prevention strategies by Subcommittee Chair Mark Souder (R-Ind.). Also asked to testify were the heads of CDC, FDA and CMS...